Quest Diagnostics Incorporated Stock Statistic Functions Linear Regression
| DGX Stock | USD 200.56 -0.34 -0.17% |
| Symbol |
Quest Diagnostics Technical Analysis Modules
Most technical analysis of Quest Diagnostics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Quest from various momentum indicators to cycle indicators. When you analyze Quest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Quest Diagnostics Incorporated
Methodology
Unless otherwise specified, financial data for Quest Diagnostics Incorporated is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Quest (USA Stocks:DGX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Quest Diagnostics Incorporated incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Quest Diagnostics Incorporated is covered by 17 analysts. 8 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Stifel, Barclays, Morgan Stanley, Wells Fargo Securities, Evercore ISI, BMO Capital Markets, HSBC Global Research, Jefferies, among others. Updates may occur throughout the day.
Become your own money manager
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Investor Favorites Invested over 60 shares | |
 | Advertising Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested over 200 shares | |
 | Driverless Cars Invested over 40 shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Macroaxis Picks Invested few shares | |
 | Social Domain Invested few shares |
More Resources for Quest Stock Analysis
A structured review of Quest Diagnostics often starts with core financial statements and trend context. Ratios and trend metrics help frame Quest Diagnostics' operating context. Key reports that frame Quest Diagnostics Incorporated Stock are listed below: Quarterly Earnings Growth 0.11 | Dividend Share 3.2 | Earnings Share 8.76 | Revenue Per Share | Quarterly Revenue Growth 0.071 |